Browse Locations ... - Condition: Acne Vulgaris
Interventions: Drug: CD0271 0.3% / CD1579 2.5%; Drug: CD0271 0.1% / CD1579 2.5%; Drug: Topical Gel Vehicle
Sponsors: Galderma R&D; Galderma R&D
Not yet recruiting - verified June 2013 - Conditions: Coronary Artery Disease; Myocardial Ischemia
Intervention:
Sponsors: Biotronik Canada Inc; Biotronik Canada Inc
Not yet recruiting - verified June 2013 - Conditions: Schizophrenia; Schizoaffective Disorder
Intervention: Device: Repetitive Transcranial Magnetic Stimulation
Sponsors: Centre for Addiction and Mental Health; Centre for Addiction and Mental Health; Canadian Institutes of Health Research (CIHR)
Not yet recruiting - verified June 2013 - Condition: Rotator Cuff Tear
Intervention: Procedure: Bone Trephination
Sponsors: Ottawa Hospital Research Institute; Dr. P. Lapner; Pan Am Clinic; London Health Sciences Centre; University of Alberta
Recruiting - verified June 2013 - Conditions: Diabetes; Hypertension; Ischemic Heart Disease
Interventions: Other: High risk; Other: Best Practice
Sponsors: Sunnybrook Health Sciences Centre; Sunnybrook Health Sciences Centre; Institute for Clinical Evaluative Sciences; Canadian Institutes of Health Research (CIHR); Heart and Stroke Foundation of Canada
Active, not recruiting - verified June 2013 - Condition: Healthy Volunteer
Interventions: Drug: MHAA4549A; Drug: Placebo
Sponsors: Genentech; Genentech
Not yet recruiting - verified June 2013 - Condition: Obstructive Sleep Apnea (OSA)
Interventions: Device: Boussignac CPAP device; Device: standard CPAP
Sponsors: Queen's University; Queen's University; Canadian Institutes of Health Research (CIHR)
Recruiting - verified June 2013 - Condition: Healthy
Interventions: Other: 50 g Coconut oil; Other: 50 g Canola oil; Other: 50 g Grapeseed oil; Other: 50 g Chia oil; Other: 50 g Butter
Sponsors: St. Michael's Hospital, Toronto; St. Michael's Hospital, Toronto
Not yet recruiting - verified May 2013 - Condition: Central Line Complication
Interventions: Device: Virtual Reality; Device: Ultrasound
Sponsors: Lawson Health Research Institute; Lawson Health Research Institute; University of Western Ontario, Canada
Recruiting - verified June 2013 - Condition: Diabetic Nephropathies
Interventions: Drug: BAY94-8862; Drug: Placebo
Sponsors: Bayer; Bayer
Not yet recruiting - verified June 2013 - Conditions: Alcohol Consumption; Hazardous Alcohol Consumption
Interventions: Behavioral: Check Your Drinking; Behavioral: Alcohol Help Centre
Sponsors: Centre for Addiction and Mental Health; Centre for Addiction and Mental Health
Recruiting - verified June 2013 - Conditions: Concussions; PCS
Intervention:
Sponsors: Children's Hospital of Eastern Ontario; Children's Hospital of Eastern Ontario; Canadian Institutes of Health Research (CIHR)
Not yet recruiting - verified June 2013 - Conditions: Post-concussion Syndrome; Post-concussive Symptoms; Traumatic Brain Injury; Concussion; Children
Interventions: Dietary Supplement: Melatonin; Dietary Supplement: Sugar pill
Sponsors: University of Calgary; University of Calgary; Children's Hospital of Eastern Ontario
Not yet recruiting - verified June 2013 - Conditions: Health; Appetite Regulation; Glucose Metabolism
Intervention: Other: Dietary intervention
Sponsors: University of Toronto; University of Toronto
Completed - verified June 2013 - Condition: Nicotine Dependence.
Interventions: Drug: Gemfibrozil; Drug: Placebo
Sponsors: Centre for Addiction and Mental Health; Centre for Addiction and Mental Health; Pfizer
Not yet recruiting - verified June 2013 - Conditions: Dilated Cardiomyopathy; Hypertrophic Cardiomyopathy
Intervention:
Sponsors: University of Miami; University of Miami; New England Research Institutes; Washington University School of Medicine; Children's Hospital Boston; Columbia University; Children's Hospital of Philadelphia; Ann & Robert H Lurie Children's Hospital of Chicago; Primary Children's Medical Center; Monroe Carell Jr Children's Hospital at Vanderbilt; Stollery Children's Hospital; Children's Hospital Medical Center, Cincinnati; Montefiore Medical Center
Not yet recruiting - verified June 2013 - Conditions: Dilated Cardiomyopathy; Hypertrophic Cardiomyopathy; Restrictive Cardiomyopathy
Intervention:
Sponsors: University of Miami; University of Miami; New England Research Institutes; Children's Hospital Medical Center, Cincinnati; Washington University School of Medicine; Children's Hospital of Philadelphia; Columbia University; Children's Hospital Boston; Ann & Robert H Lurie Children's Hospital of Chicago; Primary Children's Medical Center; Monroe Carell Jr Children's Hospital at Vanderbilt; Stollery Children's Hospital
Recruiting - verified June 2013 - Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: lebrikizumab; Drug: placebo
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Not yet recruiting - verified June 2013 - Condition: Partial Onset Seizures
Intervention: Drug: Perampanel
Sponsors: Eisai Inc.; Eisai Inc.
Available - verified June 2013 - Conditions: Type 2 Diabetes; Diabetic Nephropathy; Hypertension; Sleep Apnea
Interventions: Device: NCPAP; Nasal continuous positive airway pressure.; Device: NCPAP Nasal Continuous Positive Airway Pressure-sub-therapeutic treatment group
Sponsors: Ottawa Hospital Research Institute; Ottawa Hospital Research Institute
Recruiting - verified June 2013 - Condition: Spondylitis, Ankylosing
Interventions: Drug: Ixekizumab; Drug: Placebo; Drug: Adalimumab
Sponsors: Eli Lilly and Company; Eli Lilly and Company
Not yet recruiting - verified June 2013 - Conditions: Phenylketonuria; Hyperphenylalaninemia
Intervention:
Sponsors: Hamilton Health Sciences Corporation; Hamilton Health Sciences Corporation; McMaster Children's Hospital; Children's Hospital of Eastern Ontario; BioMarin Pharmaceutical
Recruiting - verified June 2013 - Conditions: Glycaemia; Insulinemia
Interventions: Other: Reference Glucose; Other: Food Product A: Corn Flakes; Other: Food Product B: Ginger Bread; Other: Food Product C:Sandwiched Breakfast Biscuit; Other: Food Product D: Crackers Nature; Other: Food Product E: Breakfast Biscuit; Other: Food Product F: White Bread
Sponsors: Mondelēz International, Inc.; Mondelēz International, Inc.; BioFortis; Glycemic Index Laboratories, Inc; University of Sydney
Recruiting - verified June 2013 - Conditions: Nerve Block; Pain, Postoperative
Interventions: Procedure: Local anesthetic infusion; Procedure: Placebo
Sponsors: University of Alberta; University of Alberta
Recruiting - verified February 2013 - Condition: Pain, Postoperative
Intervention: Procedure: Local anesthetic injection
Sponsors: University of Alberta; University of Alberta
Recruiting - verified November 2011 - Conditions: Urolithiasis; Adults
Interventions: Drug: Ciprofloxacin; Drug: Placebo; Procedure: Extracorporeal Shock Wave Lithotripsy
Sponsors: Lawson Health Research Institute; Lawson Health Research Institute; The Physicians' Services Incorporated Foundation; St. Joseph's Health Care Foundation
Not yet recruiting - verified June 2013 - Conditions: Greater Palatine Nerve Block; Inferior Alveolar Nerve Block
Intervention: Procedure: US guided block
Sponsors: Lawson Health Research Institute; Lawson Health Research Institute
Not yet recruiting - verified June 2013 - Condition: Bladder Cancer
Interventions: Drug: Tranexamic Acid; Drug: Placebo
Sponsors: Ottawa Hospital Research Institute; Ottawa Hospital Research Institute; Canadian Institutes of Health Research (CIHR); Dalhousie University; McGill University Health Center; Centre hospitalier de l'Université de Montréal (CHUM); Laval University; University of Western Ontario, Canada; University of Alberta
Not yet recruiting - verified May 2013 - Condition: Postpartum Hemorrhage
Interventions: Drug: Oxytocin; Drug: Ergot; Drug: Carboprost
Sponsors: Samuel Lunenfeld Research Institute, Mount Sinai Hospital; Samuel Lunenfeld Research Institute, Mount Sinai Hospital
Recruiting - verified May 2013 - Conditions: Cardiovascular Disease; Sudden Cardiac Death
Intervention: Behavioral: Patient Decision Aid for an ICD (primary prevention, non-CRT)
Sponsors: McMaster University; McMaster University
Recruiting - verified June 2013 - Conditions: Severe Sepsis; Septic Shock; Bacteremia
Intervention:
Sponsors: University of British Columbia; University of British Columbia
Not yet recruiting - verified May 2013 - Condition: Sleep Apnea, Obstructive
Intervention: Behavioral: Sleeping with denture
Sponsors: Université de Montréal; Université de Montréal
Not yet recruiting - verified June 2013 - Condition: Acute Coronary Syndrome
Interventions: Other: Drug Eluting Stent; Other: Bare Metal Stent
Sponsors: University of Saskatchewan; University of Saskatchewan
Recruiting - verified March 2012 - Condition: Newborn Infant
Interventions: Procedure: Flow waves; Procedure: ECO2
Sponsors: University of Alberta; University of Alberta
Recruiting - verified May 2013 - Condition: Multiple Sclerosis
Interventions: Drug: Placebo; Drug: AIN457
Sponsors: Novartis; Novartis Pharmaceuticals
Not yet recruiting - verified June 2013 - Conditions: Nutritional Disorders; Obesity; Development
Intervention:
Sponsors: The Hospital for Sick Children; The Hospital for Sick Children
Recruiting - verified May 2013 - Condition: Wheeze
Interventions: Other: hypertonic saline; Other: saline
Sponsors: Queen's University; Michael Flavin
Not yet recruiting - verified May 2013 - Condition: Pregnancy
Interventions: Procedure: Ultrasound; Device: The spinal needle
Sponsors: Samuel Lunenfeld Research Institute, Mount Sinai Hospital; Samuel Lunenfeld Research Institute, Mount Sinai Hospital
Recruiting - verified June 2013 - Condition: Postpartum Hemorrhage
Intervention: Drug: Oxytocin
Sponsors: Samuel Lunenfeld Research Institute, Mount Sinai Hospital; Samuel Lunenfeld Research Institute, Mount Sinai Hospital
Recruiting - verified May 2013 - Condition: Stress Urinary Incontinence
Interventions: Procedure: AdVance® sling procedure; Procedure: ARGUS Sling procedure
Sponsors: Jewish General Hospital; Jewish General Hospital; Center Hospitalier de Fleurimont,Sherbrooke University; Sunnybrook Health Sciences Centre
Recruiting - verified May 2013 - Conditions: Intubation, Endotracheal; Anesthesia, General
Intervention: Device: GlideScope
Sponsors: Samuel Lunenfeld Research Institute, Mount Sinai Hospital; Samuel Lunenfeld Research Institute, Mount Sinai Hospital
Recruiting - verified May 2013 - Condition: Subarachnoid Hemorrhage, Aneurysmal
Intervention: Drug: Etanercept
Sponsors: St. Michael's Hospital, Toronto; St. Michael's Hospital, Toronto
Not yet recruiting - verified May 2013 - Condition: Cardiac Resynchronization Therapy
Intervention: Other: SonR optimization on
Sponsors: Sorin Group; Sorin Group
Not yet recruiting - verified May 2013 - Condition: End Stage Kidney Disease
Intervention: Other: exercise
Sponsors: University of Calgary; University of Calgary
Recruiting - verified June 2013 - Conditions: Bowel Preparation; Colon Capsule Completion Rates
Interventions: Drug: Prucalopride 2mg; Drug: PEG; Procedure: Colon Capsule; Procedure: Colonoscopy
Sponsors: Queen's University; Queen's University; Gastrointestinal Diseases Research Unit
Not yet recruiting - verified May 2013 - Condition: Cleft Palate
Intervention: Device: Acellular Dermal Matrix
Sponsors: McGill University Health Center; Mirko S. Gilardino
Recruiting - verified May 2013 - Condition: Muscular Dystrophy, Duchenne
Interventions: Drug: Tadalafil; Drug: Placebo
Sponsors: Eli Lilly and Company; Eli Lilly and Company
Not yet recruiting - verified June 2013 - Condition: Medial Knee Osteoarthritis
Interventions: Device: Lateral customized foot orthoses; Device: Knee brace; Device: Combination of the two treatments
Sponsors: Laval University; Laval University; Natural Sciences and Engineering Research Council, Canada; Fonds de Recherche du Québec - Nature et Technologies; Ergorecherche, Inc.
Active, not recruiting - verified June 2013 - Condition: Prostate Cancer
Interventions: Drug: Metformin; Drug: Placebo
Sponsors: University Health Network, Toronto; University Health Network, Toronto
Not yet recruiting - verified May 2013 - Condition: Cerebral Ischemia
Interventions: Device: NIRS and Algorithm; Device: NIRS derived cerebral oximetry
Sponsors: University of Manitoba; University of Manitoba
Recruiting - verified February 2013 - Condition: Children Receiving Ventilation at Home for Chronic Illness or Disease
Intervention:
Sponsors: University of British Columbia; University of British Columbia
Not yet recruiting - verified May 2013 - Condition: Crohn Disease,
Intervention: Dietary Supplement: Vitamin D3
Sponsors: University of Saskatchewan; University of Saskatchewan; Dania Alrefai; Dr.Jennifer Jones; Dr.Hani Jawa; Dr.Wael El-matary; Saudi Arabian Cultural Bureau
Not yet recruiting - verified May 2013 - Condition: Glioblastoma
Interventions: Drug: bevacizumab [Avastin]; Drug: temozolomide; Radiation: Radiotherapy; Drug: bevacizumab [Avastin]; Drug: placebo; Drug: SOC
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Not yet recruiting - verified June 2013 - Conditions: Lymphoblastic Leukemia, Acute, Childhood; Myelogenous Leukemia, Acute, Childhood
Interventions: Drug: Azacitidine; Drug: Fludarabine; Drug: Cytarabine
Sponsors: Therapeutic Advances in Childhood Leukemia Consortium; Therapeutic Advances in Childhood Leukemia Consortium; Gateway for Cancer Research; USC/Norris Comprehensive Cancer Center
Not yet recruiting - verified May 2013 - Conditions: Enuresis; Obstructive Sleep Apnea; Sleep Disordered Breathing
Interventions: Device: Bed Alarm; Drug: Nasonex
Sponsors: University of Alberta; University of Alberta
Recruiting - verified May 2013 - Condition: Insomnia
Interventions: Behavioral: Professionally-administered cognitive-behavioral therapy for insomnia (CBT-I); Behavioral: Web-based cognitive-behavioral therapy for insomnia (CBT-I)
Sponsors: Centre Hospitalier Universitaire de Québec, CHU de Québec; Centre Hospitalier Universitaire de Québec, CHU de Québec
Not yet recruiting - verified May 2013 - Conditions: Kidney Transplant; Kidney Pancreas Transplant; Edema
Intervention: Device: Geko device
Sponsors: Lawson Health Research Institute; Lawson Health Research Institute
Not yet recruiting - verified May 2013 - Condition: Atopic Dermatitis
Interventions: Drug: Dupilumab (REGN668/ SAR231893); Drug: Placebo
Sponsors: Regeneron Pharmaceuticals; Regeneron Pharmaceuticals; Sanofi
Recruiting - verified May 2013 - Condition: Sport-related Concussion
Interventions: Other: Control postural education, general range of motion and strengthening in addition to the standard of care; Other: Physiotherapy
Sponsors: Sport Injury Prevention Research Centre; Sport Injury Prevention Research Centre; Alberta Centre for Child, Family & Community Research; University of Calgary; University of British Columbia
Completed - verified May 2013
 |
Paid Research Studies in Canada |
Clinical Trial Locations 